Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co., Ltd. has predicted net loss of CNY 20 million to CNY 35 million in the first half of 2013. A year ago, the company made profit of CNY 223.4496 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.86 CNY | +0.17% | -1.84% | -25.06% |
1st Jan change | Capi. | |
---|---|---|
-25.06% | 468M | |
+27.42% | 76.68B | |
-0.60% | 24.41B | |
+7.82% | 8.81B | |
+10.46% | 8.48B | |
-25.33% | 7.47B | |
+15.02% | 5.21B | |
-8.45% | 3.86B | |
-3.20% | 3.56B | |
+14.22% | 3.4B |
- Stock Market
- Equities
- 600829 Stock
- News HPGC Renmintongtai Pharmaceutical Corporation
- Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co., Ltd. Provides Earnings Guidance for the First Half of 2013